Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers

Conditions:   Thyroid Carcinoma;   Thyroid Cancer;   Thyroid Cancer, Follicular;   Thyroid Cancer (Follicular Cell);   Thyroid Cancer, Papillary;   BRAF V600E Mutation Positive Interventions:   Diagnostic Test: I-124 PET/CT lesion dosimetry;   Drug: Vemurafenib;   Drug: Copanlisib Sponsor:   Memorial Sloan Kettering Cancer Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials